Using liposomes as carriers for polyphenolic compounds: The case of Trans-resveratrol

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Bonechi, Claudia ^a   Martini, Silvia ^a   Ciani, Laura ^b   Lamponi, Stefania ^a   Rebmann, Herbert ^c   Rossi, Claudio ^a   Ristori, Sandra ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Phospholipid Research Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPOSOME; PHOSPHATIDYLCHOLINE; POLYPHENOL DERIVATIVE; RESVERATROL;

ANIMAL CELL; ARTICLE; ASTROCYTE; CALIBRATION; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELECTRON SPIN RESONANCE; FIBROBLAST; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIGHT SCATTERING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; X RAY CRYSTALLOGRAPHY; ZETA POTENTIAL;

ANIMALS; CELL LINE; DRUG DELIVERY SYSTEMS; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MODELS, THEORETICAL; NIH 3T3 CELLS; POLYPHENOLS; STILBENES;

EID: 84865176466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041438     Document Type: Article

References (26)

1. Baur JA, Sinclair DA, (2006) Therapeutic potential of resveratrol: the in vivo evidence. Natural Review of Drug Discovery 5: 493-506.
2. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
3. Aziz MH, Kumar R, Ahmad N, (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). International Journal of Oncology 23: 17-28.
4. Fremont L, (2000) Biological effects of resveratrol. Life Science 66: 663-673.
5. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Research 24: 2783-2840.
6. Shu X-H, Li H, Sun Z, Wu M-L, Ma J-X, et al. (2010) Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells. Biochemical Pharmacology 79: 1516-25.
7. Shu X-H, Li H, Sun X-X, Wang Q, Sun Z, et al. (2011) Metabolic Patterns and Biotransformation Activities of Resveratrol in Human Glioblastoma Cells: Relevance with Therapeutic Efficacies. PLoSone 6: 27484.
8. Rius C, Abou-Taha M, Hermenegildo C, Piqueras L, Cerda-Nicolas JM, et al. (2012) Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation. Immunology 185: 3718-27.
9. Gregoriadis G, Florence AT, Patel HM Eds (1993) "Liposomes in drug delivery" Taylor & Francis Ltd, London.
10. Mauer N, Fenske DB, Cullis PR, (2001) Developments in liposomal drug delivery systems. Expert Opinion in Biological Therapy 6: 923-47.
11. Fahr A, van Hoogevest P, May S, Bergstrand N, Leigh MLS, (2005) Transfer of lipophilic drugs between liposomal membranes and biological interfaces: Consequences for drug delivery. European Journal of Pharmaceutical Sciences 26: 251-265.
12. Padamwar MN, Pokharkar VB, (2006) Development of vitamin-loaded topical liposomal formulation using factorial design approach: drug deposition and stability. International Journal of Pharmaceutics 320: 37-44.
13. Narayanan NK, Nargi D, Randolph C, Narayanan BA, (2009) Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. International Journal of Cancer 125: 1-8.
14. Caddeo C, Teskač K, Sinico C, Kristl J, (2008) Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. International Journal of Pharmaceutics 363: 183-191.
15. Kolouchová-Hanzlíková I, Melzoch K, Filip V, Šmidrkal J, (2004) Rapid method for resveratrol determination by HPLC with electrochemical and UV detections in wines. Food Chemistry 87: 151-158.
16. Koppel DE, (1972) Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants. Journal of Chemical Physics 57: 4814-4820.
17. Hunter RJ (1988) "Zeta Potential in Colloid Science: Principles And Application" Academic Press, UK.
18. Lindner P, Zemb T Eds (2002) "Neutron, X-rays and Light. Scattering Methods Applied to Soft Condensed Matter" North Holland Press, Amsterdam.
19. Pabst G, (2006) Global properties of biomimetic membranes: perspectives on molecular features. Biophysisical Review Letters 1: 57-84.
20. Delaglio F, Grzesiek S, Vuister G, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. Journal of Biomolecular NMR 6: 277-293 2D spectra were analyzed using SPARKY package (T.D. Goddard and D.G. Kneller, SPARKY program version (3.6), University of California, San Francisco.
21. Rossi C, Foletti A, Magnani A, Lamponi S, (2011) New perspectives in cell communication: Bioelectromagnetic interactions. Seminars in Cancer Biology 21: 207-214.
22. Cevc G, (1993) Electrostatic characterization of liposomes. Chemistry and Physics of Lipids 64: 163-186.
23. Bonechi C, Martini S, Magnani A, Rossi C, (2008) Stacking interaction study of trans-resveratrol (trans-3,5,4-trihydroxystilbene) in solution by Nuclear Magnetic Resonance and Fourier Transform Infrared Spectroscopy. Magnetic Resonance in Chemistry 46: 625-629.
24. Romberg B, Kettenes-van den Bosch JJ, de Vringer T, Storm G, Hennink WE, (2006) 1H NMR spectroscopy as a tool for determining the composition of poly(hydroxyethyl L-asparagine)-coated liposomes. Bioconjugate Chemistry 17: 860-864.
25. Morandi S, Ristori S, Berti D, Panza L, Becciolini, et al. (2004) Association of sugar-based carboranes with cationic liposomes: an electron spin resonance and light scattering study. Biochimica et Biophysica Acta Biomembranes 1664: 53-63.
26. Vartorelli MN, Garay AS, Rodrigues DE, (2008) Spin-labeled Stearic Acid Behavior and Perturbations on the Structure of a Gel-Phase-Lipid Bilayer in Water: 5-, 12- and 16-SASL. Journal of Physical Chemistry B 112: 16830-16842.